ANGLE plc (LON:AGL)‘s stock had its “corporate” rating reiterated by FinnCap in a report issued on Tuesday. They presently have a GBX 108 ($1.42) price target on the stock. FinnCap’s price target indicates a potential upside of 160.24% from the company’s current price.

ANGLE plc (LON:AGL) opened at GBX 41.50 ($0.55) on Tuesday. ANGLE plc has a 12-month low of GBX 32.27 ($0.42) and a 12-month high of GBX 80 ($1.05).

COPYRIGHT VIOLATION WARNING: This news story was posted by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The correct version of this news story can be read at

About ANGLE plc

ANGLE plc is a holding company. The Company’s principal activity is undertaken in relation to the commercialization of its Parsortix cell separation system, with deployment in non-invasive cancer diagnostics. The Company is a specialist medical diagnostic company, which offers products for cancer diagnostics and fetal health.

Receive News & Ratings for ANGLE plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE plc and related companies with Analyst Ratings Network's FREE daily email newsletter.